Raymond James & Associates’s Hyliion Holdings HYLN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$26.3K Sell
10,610
-490
-4% -$986 ﹤0.01% 3922
2024
Q2
$18K Hold
11,100
﹤0.01% 3897
2024
Q1
$19.5K Hold
11,100
﹤0.01% 3875
2023
Q4
$9.03K Sell
11,100
-1,500
-12% -$1.06K ﹤0.01% 3799
2023
Q3
$14.9K Buy
12,600
+2,500
+25% +$3.74K ﹤0.01% 3745
2023
Q2
$16.9K Buy
+10,100
New +$17K ﹤0.01% 3782
2021
Q4
Sell
-210,050
Closed -$1.76M 4208
2021
Q3
$1.76M Buy
210,050
+169,288
+415% +$1.56M ﹤0.01% 2192
2021
Q2
$475K Buy
40,762
+5,435
+15% +$56.8K ﹤0.01% 3113
2021
Q1
$377K Sell
35,327
-61,808
-64% -$968K ﹤0.01% 3210
2020
Q4
$1.6M Buy
+97,135
New +$2.21M ﹤0.01% 2031

Other funds holding HYLN

Raymond James & Associates's HYLN Position: Q3 2024 in Review

Raymond James & Associates reduced its Hyliion Holdings (HYLN) stake by 4.4% in Q3 2024, selling an estimated $986 and leaving 10,610 shares worth $26.3K. The position accounts for ﹤0.01% of the portfolio, ranked #3922.

Raymond James & Associates first reported a position in HYLN in Q4 2020 and has held it in 10 quarters since. The position peaked at $1.76M in Q3 2021. 110 funds tracked by Wall St. Rank hold HYLN as of Q3 2024.

  • Raymond James & Associates held 10,610 shares of Hyliion Holdings worth $26.3K as of Q3 2024.
  • Raymond James & Associates sold 490 Hyliion Holdings shares in Q3 2024, an estimated $986.
  • Hyliion Holdings made up ﹤0.01% of Raymond James & Associates's portfolio in Q3 2024, its #3922 holding.
  • Raymond James & Associates first reported a position in Hyliion Holdings in Q4 2020 and has held it in 10 quarters since.
  • Raymond James & Associates's Hyliion Holdings position peaked at $1.76M in Q3 2021.
  • 110 funds tracked by Wall St. Rank held Hyliion Holdings as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.